← Leaderboards
Uwe Rudolph
Mclean Hospital
$10,609,727
Attributed
$10,609,727
Total exposure
13
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2009–25$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,609,727 · 13
By mechanism
R01$7,378,146 · 4
R35$883,317 · 1
R21$866,630 · 2
R03$783,680 · 5
R56$697,954 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Neurons”
- Hongkui Zeng · Allen Institute$106,358,289
- Eric Martin McDade · Washington University$94,632,845
- Ed Lein · Allen Institute$90,858,363
- Randall J Bateman · Washington University$65,841,935
- John Morris · Washington University$65,018,684
- Paul S. Aisen · Cognition Therapeutics, Inc.$58,570,460
Research focus
NeuronsReceptorBehaviorMediatingBaseGeneticBehavioralPharmaceutical PreparationsMolecularBenzodiazepinesAnxietyPlayHippocampus (Brain)RegulationDiazepamMemoryCognitive DeficitsDentate GyrusResearch StudyPathway InteractionsAffectFundingLinkAgonist
Grant awards (37)
Postoperative Neurocognitive Disorder - Strategies for Prevention or Reversal Based on Molecular ad Cellular Mechanisms$436,150
R35 · FY2025 · GM · contact PI
Postoperative Neurocognitive Disorder - Strategies for Prevention or Reversal Based on Molecular ad Cellular Mechanisms$447,167
R35 · FY2024 · GM · contact PI
Cellular mechanisms for age-related cognitive dysfunction and its pharmacological reversal: a strategy towards prevention and treatment of postoperative cognitive deficits in elderly patients$388,547
R01 · FY2022 · GM · contact PI
Cellular mechanisms for age-related cognitive dysfunction and its pharmacological reversal: a strategy towards prevention and treatment of postoperative cognitive deficits in elderly patients$388,907
R01 · FY2021 · GM · contact PI
Cellular mechanisms for age-related cognitive dysfunction and its pharmacological reversal: a strategy towards prevention and treatment of postoperative cognitive deficits in elderly patients$388,546
R01 · FY2020 · GM · contact PI
Cellular mechanisms for age-related cognitive dysfunction and its pharmacological reversal: a strategy towards prevention and treatment of postoperative cognitive deficits in elderly patients$33,200
R01 · FY2020 · GM · contact PI
Cellular mechanisms for age-related cognitive dysfunction and its pharmacological reversal: a strategy towards prevention and treatment of postoperative cognitive deficits in elderly patients$438,765
R01 · FY2019 · GM · contact PI
Role of glycine decarboxylase in regulating NMDA receptor function$334,421
R56 · FY2019 · MH · contact PI
Role of glycine decarboxylase in regulating NMDA receptor function$363,533
R56 · FY2018 · MH · contact PI
A GABA Pathway to Faster Acting Antidepressants$395,000
R01 · FY2016 · MH · contact PI
A GABA Pathway to Faster Acting Antidepressants$395,000
R01 · FY2015 · MH · contact PI
Neurobiological relevance of 9p24.1 CNVs for bipolar disorder and schizophrenia$237,000
R21 · FY2015 · MH · contact PI
A GABA Pathway to Faster Acting Antidepressants$395,000
R01 · FY2014 · MH · contact PI
Neurobiological relevance of 9p24.1 CNVs for bipolar disorder and schizophrenia$197,500
R21 · FY2014 · MH · contact PI
A GABA Pathway to Faster Acting Antidepressants$379,200
R01 · FY2013 · MH · contact PI
Genetic Mapping of Neuronal Circuits Involved in Regulation of Anxiety and Fear$375,408
R01 · FY2013 · MH · contact PI
The Role of GABA A Receptor Subtypes in Benzodiazepine Abuse Liability$75,840
R03 · FY2013 · DA · contact PI
Emotional regulation: Modeling GABA A receptor subtype specific agents in mice$75,840
R03 · FY2013 · MH · contact PI
Regional actions of general anesthetics in inhibitory hippocampal networks$449,631
R01 · FY2012 · GM · contact PI
A GABA Pathway to Faster Acting Antidepressants$395,000
R01 · FY2012 · MH · contact PI
Genetic Mapping of Neuronal Circuits Involved in Regulation of Anxiety and Fear$391,050
R01 · FY2012 · MH · contact PI
The Role of GABA A Receptor Subtypes in Benzodiazepine Abuse Liability$79,000
R03 · FY2012 · DA · contact PI
Emotional regulation: Modeling GABA A receptor subtype specific agents in mice$79,000
R03 · FY2012 · MH · contact PI
Regional actions of general anesthetics in inhibitory hippocampal networks$447,349
R01 · FY2011 · GM · contact PI
Genetic Mapping of Neuronal Circuits Involved in Regulation of Anxiety and Fear$391,050
R01 · FY2011 · MH · contact PI
Generation of etiological models for schizophrenia by chromosome engineering$234,630
R21 · FY2011 · MH · contact PI
Regional actions of general anesthetics in inhibitory hippocampal networks$452,383
R01 · FY2010 · GM · contact PI
Genetic Mapping of Neuronal Circuits Involved in Regulation of Anxiety and Fear$380,500
R01 · FY2010 · MH · contact PI
Generation of etiological models for schizophrenia by chromosome engineering$197,500
R21 · FY2010 · MH · contact PI
GABAA subtype-specific pharmacological modulation of reward-related behavior$79,000
R03 · FY2010 · DA · contact PI
Psychostimulant actions: essential role of a2-GABA-A receptors in the NAc$79,000
R03 · FY2010 · DA · contact PI
Antidepressant-like and reward-related functions of a2-containing GABAA receptors$79,000
R03 · FY2010 · MH · contact PI
Regional actions of general anesthetics in inhibitory hippocampal networks$513,110
R01 · FY2009 · GM · contact PI
Genetic Mapping of Neuronal Circuits Involved in Regulation of Anxiety and Fear$380,500
R01 · FY2009 · MH · contact PI
GABAA subtype-specific pharmacological modulation of reward-related behavior$79,000
R03 · FY2009 · DA · contact PI
Psychostimulant actions: essential role of a2-GABA-A receptors in the NAc$79,000
R03 · FY2009 · DA · contact PI
Antidepressant-like and reward-related functions of a2-containing GABAA receptors$79,000
R03 · FY2009 · MH · contact PI